Trial Profile
3D Multi-contrast Atherosclerosis Characterization (MATCH) of the Carotid Artery Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Feb 2024
Price :
$35
*
At a glance
- Drugs Gadoversetamide (Primary)
- Indications Carotid artery diseases
- Focus Diagnostic use
- Acronyms MATCH
- 13 Feb 2024 Status changed from recruiting to completed.
- 06 Feb 2023 Planned End Date changed from 1 Jun 2022 to 1 Dec 2024.
- 06 Feb 2023 Planned primary completion date changed from 1 Jun 2022 to 1 Dec 2024.